Rationalizing Duration of Dual Antiplatelet Therapy After Coronary Stenting

$0I01FY2020VAVA

Va Boston Health Care System, Boston MA

Investigators

Scott Kinlaycontact

Linked publications & trials

Paper 39525994 Paper 37758389 Paper 37666014 Paper 37522805 Paper 37211818 Paper 36137673 Paper 35085747 Paper 33899501 Paper 32019343 Paper 30747602 Paper 30682202 Paper 30611122 Paper 29992854 Paper 28385411 Paper 27860195

View original record on NIH RePORTER →

Rationalizing Duration of Dual Antiplatelet Therapy After Coronary Stenting · GrantIndex